Dowling & Yahnke’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-762
| Closed | -$8K | – | 308 |
|
|
2020
Q2 | $8K | Hold |
762
| – | – | ﹤0.01% | 293 |
|
|
2020
Q1 | $4K | Hold |
762
| – | – | ﹤0.01% | 289 |
|
|
2019
Q4 | $5K | Hold |
762
| – | – | ﹤0.01% | 354 |
|
|
2019
Q3 | $5K | Hold |
762
| – | – | ﹤0.01% | 305 |
|
|
2019
Q2 | $6K | Hold |
762
| – | – | ﹤0.01% | 294 |
|
|
2019
Q1 | $11K | Hold |
762
| – | – | ﹤0.01% | 256 |
|
|
2018
Q4 | $13K | Hold |
762
| – | – | ﹤0.01% | 248 |
|
|
2018
Q3 | $17K | Hold |
762
| – | – | ﹤0.01% | 281 |
|
|
2018
Q2 | $15K | Hold |
762
| – | – | ﹤0.01% | 274 |
|
|
2018
Q1 | $8K | Hold |
762
| – | – | ﹤0.01% | 281 |
|
|
2017
Q4 | $15K | Hold |
762
| – | – | ﹤0.01% | 290 |
|
|
2017
Q3 | $13K | Hold |
762
| – | – | ﹤0.01% | 278 |
|
|
2017
Q2 | $28K | Hold |
762
| – | – | ﹤0.01% | 274 |
|
|
2017
Q1 | $35K | Hold |
762
| – | – | ﹤0.01% | 274 |
|
|
2016
Q4 | $20K | Hold |
762
| – | – | ﹤0.01% | 263 |
|
|
2016
Q3 | $31K | Hold |
762
| – | – | ﹤0.01% | 262 |
|
|
2016
Q2 | $40K | Hold |
762
| – | – | ﹤0.01% | 264 |
|
|
2016
Q1 | $46K | Hold |
762
| – | – | 0.01% | 256 |
|
|
2015
Q4 | $74K | Buy |
+762
| New | +$74K | 0.01% | 249 |
|